Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer.

CA 242, a novel tumour carbohydrate antigen present in serum (upper limit of normal values: 20.0 U ml-1), has been measured in a group of 102 pathologically confirmed non-small cell lung cancer patients. The aim of the present prospective study was to identify any relationship between pre-treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Pujol, J. L., Cooper, E. H., Lehmann, M., Purves, D. A., Dan-Aouta, M., Midander, J., Godard, P., Michel, F. B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968478/
https://www.ncbi.nlm.nih.gov/pubmed/8390291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968478/
https://www.ncbi.nlm.nih.gov/pubmed/8390291

Ejemplares similares